Atlas Capital Advisors LLC Novo Nordisk A S Transaction History

Atlas Capital Advisors LLC

$819 Billion
Q2 2025

A detailed history of Atlas Capital Advisors LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Atlas Capital Advisors LLC holds 268 shares of NVO stock, worth $12,987. This represents 0.0% of its overall portfolio holdings.

Number of Shares

268

Previous 268 -0.0%

Holding current value

$12,987

Previous $18.6 Million 0.6%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	SELL	$69.3 - $90.95 $395,287 - $518,778	-5,704 Reduced 95.51%	268 $18.6 Million
Q4 2024 Feb 12, 2025	SELL	$85.0 - $120.04 $39,780 - $56,178	-468 Reduced 7.27%	5,972 $514 Million
Q3 2024 Nov 05, 2024	SELL	$119.07 - $145.42 $8,334 - $10,179	-70 Reduced 1.08%	6,440 $767 Million
Q2 2024 Jul 29, 2024	SELL	$122.71 - $146.91 $206,398 - $247,102	-1,682 Reduced 20.53%	6,510 $929 Million
Q1 2024 Apr 15, 2024	SELL	$102.11 - $135.92 $102,110 - $135,920	-1,000 Reduced 10.88%	8,192 $1.05 Billion

Q4 2023 Feb 15, 2024	BUY	$87.78 - $105.45 $77,509 - $93,112	883 Added 10.63%	9,192 $951 Million
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $368,670 - $808,935	4,054 Added 95.28%	8,309 $756 Million
Q1 2023 May 16, 2023	SELL	$132.34 - $159.14 $4,499 - $5,410	-34 Reduced 0.79%	4,255 $677 Million
Q4 2022 Feb 15, 2023	SELL	$102.55 - $135.33 $232,173 - $306,387	-2,264 Reduced 34.55%	4,289 $580 Million
Q3 2022 Nov 08, 2022	SELL	$95.28 - $116.93 $47,258 - $57,997	-496 Reduced 7.04%	6,553 $653 Million
Q2 2022 Aug 16, 2022	SELL	$103.24 - $121.81 $74,952 - $88,434	-726 Reduced 9.34%	7,049 $785 Million
Q1 2022 May 11, 2022	BUY	$93.1 - $112.54 $17,782 - $21,495	191 Added 2.52%	7,775 $863 Million
Q4 2021 Feb 01, 2022	BUY	$95.88 - $117.08 $218,222 - $266,474	2,276 Added 42.88%	7,584 $849 Million
Q3 2021 Oct 28, 2021	BUY	$84.42 - $106.62 $448,101 - $565,938	5,308 New	5,308 $509,000
Q4 2018 Jan 29, 2019	SELL	$41.54 - $47.25 $246,456 - $280,334	-5,933 Closed	0 $0
Q3 2018 Nov 09, 2018	SELL	$46.76 - $51.24 $206,538 - $226,327	-4,417 Reduced 42.68%	5,933 $0
Q2 2018 Jul 30, 2018	SELL	$44.29 - $50.42 $590,917 - $672,703	-13,342 Reduced 56.31%	10,350 $0
Q1 2018 Apr 18, 2018	BUY	$48.49 - $58.14 $1.15 Million - $1.38 Million	23,692 New	23,692 $0

Others Institutions Holding NVO

# of Institutions

1,684

Shares Held

304M

Call Options Held

25.9M

Put Options Held

43.8M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $109B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlas Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atlas Capital Advisors LLC with notifications on news.

Account

Atlas Capital Advisors LLC Novo Nordisk A S Transaction History